ストックスクリーナーアプリを入手
55.87
1.54%
0.85
アフターアワーズ：
56.40
0.53
+0.95%
前日終値:
$55.02
開ける：
$55.27
24時間の取引高:
5.99M
Relative Volume:
1.70
時価総額：
$24.77B
収益：
$2.44B
当期純損益:
$1.36B
株価収益率:
29.26
EPS:
1.9093
ネットキャッシュフロー:
$574.14M
1週間 パフォーマンス:
+0.20%
1か月 パフォーマンス:
+10.77%
6か月 パフォーマンス:
+40.62%
1年 パフォーマンス:
+65.54%
1日の値動き範囲:
$55.00
$55.94
1週間の範囲:
$53.81
$56.01
52週間の値動き範囲:
$33.37
$56.07
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
Compare RPRX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
55.87 | 24.39B | 2.44B | 1.36B | 574.14M | 1.9093 |
VRTX
Vertex Pharmaceuticals Inc
|
446.83 | 112.12B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
635.45 | 65.92B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
891.32 | 52.38B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.05 | 40.54B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
149.23 | 33.10B | 742.00K | -1.37B | -1.07B | -7.0731 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | アップグレード | UBS | Neutral → Buy |
| 2025-09-30 | 開始されました | Goldman | Buy |
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Non-controlling/minority interest of Royalty Pharma Plc Class A – XETR:RPD - TradingView
(RPRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Norges Bank Invests $131.92 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
Royalty Pharma (RPRX) shareholders back directors, pay and share issuance powers at 2026 AGM - Stock Titan
Royalty Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Moomoo
Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by BNP Paribas Financial Markets - MarketBeat
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript - AOL.com
Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Stock Analysis: Evaluating Its 6.26% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Royalty Pharma Secures New $1.8 Billion Credit Facility - The Globe and Mail
Royalty Pharma signs $500M co-development agreement with J&J - MSN
Royalty Pharma stock hits 52-week high at 54.82 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at 54.82 USD - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX - MarketBeat
Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares - Investing.com India
RPRX Stock Price, Quote & Chart | ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) - ChartMill
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) CFO-linked entity sells 64,399 shares under 10b5-1 plan - Stock Titan
Royalty Pharma plc Enters into Revolving Credit Agreement - marketscreener.com
Royalty Pharma (NASDAQ: RPRX) renews $1.8B unsecured revolver to 2031 - Stock Titan
Royalty Pharma Plc Hits New 52-Week High of $54.74 - Markets Mojo
Royalty Pharma Plc Hits New 52-Week High at $54.63 - Markets Mojo
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships - Sahm
Affiliates file to sell RPRX shares amid recent tranche sales (NASDAQ: RPRX) - Stock Titan
10% Of This Royalty Pharma Insider's Holdings Were Sold - 富途牛牛
Responsive Playbooks and the RPRX Inflection - Stock Traders Daily
HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential - Yahoo Finance
Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments - DirectorsTalk Interviews
Royalty Pharma Plc Hits New 52-Week High of USD 53.59 - Markets Mojo
Cumberland Partners Ltd Buys Shares of 35,000 Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma stock hits 52-week high at 53.48 USD By Investing.com - Investing.com Australia
Royalty Pharma EVP Marshall Urist sells $721,837 in shares By Investing.com - Investing.com India
Royalty Pharma PLC $RPRX Shares Bought by Handelsbanken Fonder AB - MarketBeat
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells 13,684 Shares of Stock - MarketBeat
Royalty Pharma EVP Marshall Urist sells $721,837 in shares - Investing.com
Royalty Pharma (RPRX) EVP Urist sells 13,684 shares in 10b5-1 planned trade - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Hits New 12-Month HighWhat's Next? - MarketBeat
Royalty Pharma stock hits 52-week high at 53.48 USD - Investing.com
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $4.92 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (NASDAQ: RPRX) Rule 144 notice for 13,684-share resale - Stock Titan
ROYAL LONDON ASSET MANAGEMENT LTD's Royalty Pharma PLC(RPRX) Holding History - GuruFocus
Thrivent Financial for Lutherans Acquires 22,015 Shares of Royalty Pharma PLC $RPRX - MarketBeat
49,855 Shares in Royalty Pharma PLC $RPRX Acquired by Partners Group Holding AG - MarketBeat
Marathon Asset Management Ltd Has $15 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Acquired by Cullen Frost Bankers Inc. - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
1.69%
1.13%
大文字化:
|
ボリューム (24 時間):